CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Cipla Ltd

Cipla Ltd

BSE 500087 CIPLA INE059A01026
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals NIFTY 50NIFTY 500

Filing rhythm · 30 trading days

21 filings · 8 material · busiest 2026-07-23

What it files

General10 Change in Management2 Scheme of Arrangement1 ESOP Allotment1 Concall Transcript1 Newspaper Publication1 Results1 Investor Presentation1

Filings

21 in the window

  1. 25 August 2026

    General

    USFDA Inspection At Company'S Manufacturing Facility In Pithampur, India

    Please find enclosed disclosure

    Company Update / General View filing →

  2. 19 August 2026

    Scheme of Arrangement

    Scheme of Arrangement

    Cipla has informed the exchange about receipt of order from Hon'ble NCLT, Mumbai Bench

    Company Update / Scheme of Arrangement View filing →

  3. 11 August 2026

    General

    Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find attached disclosure on ESG Ratings.

    Company Update / General View filing →

  4. 4 August 2026

    General

    Update On USFDA Inspection At Invagen Manufacturing Facility In Hauppauge, Long Island, New York, USA

    Please find enclosed intimation.

    Company Update / General View filing →

  5. 31 July 2026

    ESOP Allotment

    Allotment of ESOP / ESPS

    In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirments) Regulations, 2015, we hereby notify that the Operations and Administrative Committee ....

    Company Update / Allotment of ESOP / ESPS View filing →

  6. 27 July 2026

    Concall Transcript

    Earnings Call Transcript

    Please find enclosed Earnings Call Transcript - Q1FY27

    Company Update / Earnings Call Transcript View filing →

  7. 27 July 2026

    General

    Cipla Receives U.S. FDA Approval For Generic Advair Diskus®

    Please find enclosed disclosure

    Company Update / General View filing →

  8. 24 July 2026

    Newspaper Publication

    Newspaper Publication

    Please find attached newspaper intimation for unaudited financial results for the quarter ended 30th June, 2026.

    Company Update / Newspaper Publication View filing →

  9. 23 July 2026

    Results

    Financial Results For Quarter Ended 30Th June, 2026

    Please find attached financial results for quarter ended 30th June, 2026

    Result / Financial Results View filing →

  10. 23 July 2026

    Investor Presentation

    Investor Presentation

    Please find attached Investor Presentation

    Company Update / Investor Presentation View filing →

  11. 23 July 2026

    Press Release

    Press Release / Media Release

    Please find attached press release for Q1FY27 financial results

    Company Update / Press Release / Media Release View filing →

  12. 23 July 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Dated 23Rd July 2026

    Please find enclosed outcome of Board meeting.

    Board Meeting / Outcome of Board Meeting View filing →

  13. 23 July 2026

    Change in Management

    Change in Management

    Please find enclosed the disclosure relating to the change in CFO.

    Company Update / Change in Management View filing →

  14. 23 July 2026

    Change in Management

    Change in Management

    Please find enclosed the disclosure relating to the change in SMP.

    Company Update / Change in Management View filing →

  15. 23 July 2026

    General

    Grant Of Stock Option And Employee Stock Appreciation Rights

    Please find enclosed disclosure

    Company Update / General View filing →

  16. 23 July 2026

    General

    500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find enclosed disclosure on Regulation 30(5)

    Company Update / General View filing →

  17. 23 July 2026

    General

    500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find enclosed disclosure

    Company Update / General View filing →

  18. 23 July 2026

    General

    Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find enclosed disclosure

    Company Update / General View filing →

  19. 23 July 2026

    General

    Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find enclosed disclosure

    Company Update / General View filing →

  20. 23 July 2026

    General

    Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find enclosed disclosure

    Company Update / General View filing →

  21. 23 July 2026

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the ....

    Company Update / Analyst / Investor Meet View filing →